Lori McDougal - EnteroMedics Director
Director
Ms. Lori C. McDougal is Director of the Company. Lori C. McDougal has served as one of our directors since July 2015 since 2015.
| Age | 55 |
| Tenure | 9 years |
| Phone | 651-634-3003 |
| Web | http://www.enteromedics.com |
EnteroMedics Management Efficiency
The company has return on total asset (ROA) of (48.42) % which means that it has lost $48.42 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (146.32) %, meaning that it created substantial loss on money invested by shareholders. EnteroMedics' management efficiency ratios could be used to measure how well EnteroMedics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| James Gentilcore | Entegris | 65 | |
| Gil Lunsen | MACOM Technology Solutions | 75 | |
| Heather Ridout | ASE Industrial Holding | 62 | |
| Rutherford Chang | ASE Industrial Holding | 44 | |
| Raymond Lo | ASE Industrial Holding | 64 | |
| Michael Splinter | Taiwan Semiconductor Manufactur | 70 | |
| Dalin Xu | ASE Industrial Holding | N/A | |
| Abraham Ludomirski | Vishay Intertechnology | 69 | |
| Guoci Chen | Taiwan Semiconductor Manufactur | N/A | |
| Ziv Shoshani | Vishay Intertechnology | 54 | |
| James Zug | Amkor Technology | 75 | |
| Nicholas Burns | Entegris | 62 | |
| Mary McCourt | Amkor Technology | 56 | |
| Robert Morse | Amkor Technology | 62 | |
| Matthew Chapman | Microchip Technology | 66 | |
| Thomas Engibous | Taiwan Semiconductor Manufactur | 61 | |
| James Lederer | Entegris | 57 | |
| Thomas Wertheimer | Vishay Intertechnology | 79 | |
| Changyi Chen | ASE Industrial Holding | N/A | |
| Marvin Burkett | Entegris | 72 | |
| Damian Roche | ASE Industrial Holding | N/A | |
Management Performance
| Return On Equity | -146.32 | |||
| Return On Asset | -48.42 |
EnteroMedics Leadership Team
Elected by the shareholders, the EnteroMedics' board of directors comprises two types of representatives: EnteroMedics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EnteroMedics. The board's role is to monitor EnteroMedics' management team and ensure that shareholders' interests are well served. EnteroMedics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EnteroMedics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jon Tremmel, Consultant To The CEO and Director | ||
| Peter Delange, Senior Vice President - Operations and Business Development | ||
| Scott Youngstrom, CFO, Chief Compliance Officer | ||
| Dan Gladney, CEO and President and Director | ||
| Nicholas Teti, Independent Director | ||
| Carl Goldfischer, Independent Director | ||
| Catherine Friedman, Independent Director | ||
| Michael Mashaal, Director | ||
| Lori McDougal, Director | ||
| Gary Blackford, Director | ||
| Nick Ansari, Senior Vice President - Sales | ||
| Scott Shikora, Executive Vice President - Medical Affairs and Chief Medical Officer | ||
| Anthony Jansz, Director | ||
| Adrianus Donders, Sr. VP of Research and Advanced Devel. | ||
| Katherine Tweden, Co-Founder and VP of Clinical and Regulatory | ||
| Mark Knudson, Founder and Executive Chairman | ||
| Gregory Lea, CFO, Principal Accounting Officer, Chief Compliance Officer and Secretary | ||
| Paul Hickey, Senior Vice President - Marketing and Reimbursement | ||
| Bobby Griffin, Independent Director | ||
| Tonya Dowd, Vice President - Reimbursement | ||
| Naqeeb Ansari, Senior Vice President - Sales |
EnteroMedics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EnteroMedics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -146.32 | |||
| Return On Asset | -48.42 | |||
| Current Valuation | 5.39 M | |||
| Shares Outstanding | 14.57 M | |||
| Shares Owned By Insiders | 6.79 % | |||
| Shares Owned By Institutions | 2.64 % | |||
| Number Of Shares Shorted | 1.13 M | |||
| Price To Earning | (0.32) X | |||
| Price To Book | 0.45 X | |||
| Price To Sales | 52.22 X |
Pair Trading with EnteroMedics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnteroMedics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnteroMedics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to FedEx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace FedEx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back FedEx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling FedEx to buy it.
The correlation of FedEx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as FedEx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if FedEx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for FedEx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in EnteroMedics Stock
If you are still planning to invest in EnteroMedics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EnteroMedics' history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |